Mode
Text Size
Log in / Sign up
N/A N=550 Randomized Single-blind Health Services Research

Evaluating a Preference-based Intervention for Increasing Colorectal Cancer Screening

Colorectal Neoplasms

Enrolled (actual)
550
Serious AEs
1.1%
Results posted
Jun 2015
Primary outcome: Primary: Colorectal Cancer (CRC) Screening Rate. — 40.1; 40.2; 19.3 percentage of participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Standard Information (Behavioral); Preference-tailored Information (Behavioral)
Age
Adult, Older Adult · 50+ yrs
Sex
All
Sponsor
US Department of Veterans Affairs
Primary completion
May 2012

Outcome Measures

OutcomeResultp-value
PRIMARY
Colorectal Cancer (CRC) Screening Rate.
40.1; 40.2; 19.3
SECONDARY
Number of Elements of Braddock's Informed Decision Making (IDM) Model Discussed With Provider
5.72; 5.70 0.873
SECONDARY
Colorectal Cancer Screening (CRCS) Knowledge and Attitudes.
13.1; 14.9; 66.2; 67.7; 20.7; 17.4 0.671
SECONDARY
Decisional Satisfaction
16.6; 29.4; 35.4; 22.8; 48; 47.7 0.002 sig
SECONDARY
Intent to Get Colorectal Cancer Screening.
76.8; 72.6 0.186
SECONDARY
Self Efficacy.
64.1; 61.4; 35.9; 38.6 0.576
SECONDARY
If Colorectal Cancer Screening Screening (CRCS) Discussed With Provider.
65.1; 67.4 0.35

Summary

The goal of this study is to evaluate whether an educational tool about colorectal cancer (CRC) completed on a computer that helps patients clarify their CRC screening preferences will lead to increased screening rates for CRC compared to standard information delivered via computer.

Eligibility Criteria

Inclusion Criteria

  • Clinic appointment at Ann Arbor or Pittsburgh VA during recruitment period.
  • Age 50-78.
  • Not up to date with CRC screening according to VA and USPSTF guidelines.
  • At average risk for CRC (no history of CRC, adenomatous colon polyps, inflammatory bowel disease, and no family history of CRC).
  • Has current address and telephone number listed in medical record.

Exclusion Criteria

  • DNR/DNI code status.
  • Metastatic cancer.
  • Stage D congestive heart failure.
  • Severe COPD.
  • Coronary artery disease (CAD) and MI within one year or CAD and unstable angina within 6 months.
  • Dementia.
  • Inability to conduct activities of daily living.
  • Life expectancy less than one year.
  • Other - anything else that limits CRC screening options.
  • Scheduled for a colonoscopy, sigmoidoscopy, DCBE, or CTC.
  • prior participation in this study
  • unable to contact after 2 introductory letters (at least 6 months apart)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00810771). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search